News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,120 Results
Type
Article (17725)
Company Profile (168)
Press Release (248227)
Section
Business (70502)
Career Advice (102)
Deals (12072)
Drug Delivery (55)
Drug Development (54196)
Employer Resources (30)
FDA (8681)
Job Trends (5991)
News (141607)
Policy (11774)
Tag
Academia (1036)
Alliances (19401)
Alzheimer's disease (833)
Antibody-drug conjugate (ADC) (66)
Approvals (8634)
Artificial intelligence (73)
Bankruptcy (81)
Best Places to Work (5571)
Biotechnology (128)
Breast cancer (167)
Cancer (1164)
Cardiovascular disease (81)
Career advice (91)
CAR-T (110)
Cell therapy (321)
Clinical research (44299)
Collaboration (343)
Compensation (136)
COVID-19 (1039)
C-suite (73)
Cystic fibrosis (77)
Data (1107)
Diabetes (105)
Diagnostics (1696)
Earnings (27003)
Events (44609)
Executive appointments (242)
FDA (9146)
Funding (250)
Gene editing (66)
Gene therapy (220)
GLP-1 (360)
Government (1489)
Healthcare (8387)
Infectious disease (1076)
Inflammatory bowel disease (88)
IPO (6629)
Job creations (741)
Job search strategy (86)
Layoffs (193)
Legal (1326)
Lung cancer (183)
Lymphoma (95)
Manufacturing (132)
Medical device (4280)
Medtech (4283)
Mergers & acquisitions (5594)
Metabolic disorders (315)
Neuroscience (1085)
NextGen Class of 2024 (2311)
Non-profit (1335)
Northern California (1146)
Obesity (180)
Opinion (83)
Parkinson's disease (80)
Patents (73)
People (20272)
Phase I (13718)
Phase II (19890)
Phase III (15060)
Pipeline (397)
Postmarket research (1590)
Preclinical (5144)
Radiopharmaceuticals (179)
Rare diseases (238)
Real estate (1492)
Regulatory (9908)
Research institute (1227)
Southern California (893)
Startups (1494)
United States (9221)
Vaccines (192)
Weight loss (132)
Date
Today (34)
Last 7 days (387)
Last 30 days (1583)
Last 365 days (21581)
2024 (21471)
2023 (23272)
2022 (27969)
2021 (29184)
2020 (24908)
2019 (18381)
2018 (13579)
2017 (14552)
2016 (12634)
2015 (14589)
2014 (9682)
2013 (7057)
2012 (7166)
2011 (7226)
2010 (6454)
Location
Africa (152)
Asia (16290)
Australia (2796)
California (2429)
Canada (635)
China (233)
Colorado (82)
Connecticut (113)
Europe (38530)
Florida (301)
Georgia (76)
Illinois (166)
Indiana (108)
Japan (67)
Maryland (334)
Massachusetts (2022)
Minnesota (155)
New Jersey (744)
New York (668)
North Carolina (482)
Northern California (1146)
Ohio (90)
Pennsylvania (605)
South America (212)
Southern California (893)
Texas (330)
Washington State (295)
266,120 Results for "biorestorative therapies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program
BioRestorative Therapies, Inc. reported that it has had substantive discussions with an undisclosed commercial stage regenerative medicine company with regard to a license of BioRestorative’s allogeneic, off-the-shelf ThermoStem® metabolic intellectual property.
June 13, 2024
·
5 min read
Business
BioRestorative Therapies Provides First Quarter 2024 Business Update
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today provided an update on its business.
May 14, 2024
·
6 min read
Pharm Country
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that CEO Lance Alstodt will participate at the Jefferies Global Healthcare Conference being held June 5-6, 2024 at the Marriot Marquis in New York.
June 4, 2024
·
3 min read
Press Releases
BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program
December 6, 2024
·
5 min read
Press Releases
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
November 1, 2024
·
5 min read
Press Releases
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
·
7 min read
Press Releases
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
November 13, 2024
·
6 min read
Pharm Country
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
BioRestorative Therapies, Inc . is pleased to announce that it has received a notice of allowance from the Japanese Patent Office for patent application No. 2021-564135 related to the Company’s allogeneic, off-the-shelf ThermoStem® platform.
June 27, 2024
·
6 min read
Press Releases
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events
October 10, 2024
·
3 min read
Press Releases
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
November 6, 2024
·
5 min read
1 of 26,612
Next
